Found: 15
Select item for more details and to access through your institution.
Recent advances in dopamine D<sub>2</sub> receptor ligands in the treatment of neuropsychiatric disorders.
- Published in:
- Medicinal Research Reviews, 2023, v. 43, n. 1, p. 55, doi. 10.1002/med.21923
- By:
- Publication type:
- Article
PHENOTHIAZINE-TACRINE HETERODIMERS: PURSUING MULTITARGET DIRECTED APPROACH IN ALZHEIMER'S DISEASE.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
2-PROPARGAYLAMINO-NAPHTHOQUINONE DERIVATIVES AS MULTIPOTENT AGENTS FOR THE TREATMENT OFALZHEIMER'S DISEASE.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
TACRINE-SQUARAMIDE DERIVATIVES AS POTENT CHOLINESTERASE INHIBITORS.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Synthesis and In Vitro Evaluation of Novel Dopamine Receptor D 2 3,4-dihydroquinolin-2(1 H)-one Derivatives Related to Aripiprazole.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 9, p. 1262, doi. 10.3390/biom11091262
- By:
- Publication type:
- Article
Cover Image, Volume 40, Issue 5.
- Published in:
- Medicinal Research Reviews, 2020, v. 40, n. 5, p. ii, doi. 10.1002/med.21616
- By:
- Publication type:
- Article
Recent advances with 5‐HT<sub>3</sub> modulators for neuropsychiatric and gastrointestinal disorders.
- Published in:
- Medicinal Research Reviews, 2020, v. 40, n. 5, p. 1593, doi. 10.1002/med.21666
- By:
- Publication type:
- Article
Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors.
- Published in:
- Biomolecules (2218-273X), 2019, v. 9, n. 8, p. 379, doi. 10.3390/biom9080379
- By:
- Publication type:
- Article
Orexin supplementation in narcolepsy treatment: A review.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 3, p. 961, doi. 10.1002/med.21550
- By:
- Publication type:
- Article
Investigation of New Orexin 2 Receptor Modulators Using In Silico and In Vitro Methods.
- Published in:
- Molecules, 2018, v. 23, n. 11, p. 2926, doi. 10.3390/molecules23112926
- By:
- Publication type:
- Article
DISCOVERY AND CHARACTERIZATION OF TACRINE/HUPRINE-TRYPTOPHAN HETERODIMERS AS NOVEL MULTIPOTENT COMPOUNDS AGAINST ALZHEIMER'S DISEASE.
- Published in:
- Military Medical Science Letters / Vojenské zdravotnické Listy, 2018, v. 87, p. 71
- By:
- Publication type:
- Article
7-MEOTA-DONEPEZIL HYBRIDS: POTENTIAL CHOLINESTERASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE.
- Published in:
- Military Medical Science Letters / Vojenské zdravotnické Listy, 2018, v. 87, p. 128
- By:
- Publication type:
- Article
Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy.
- Published in:
- Molecules, 2017, v. 22, n. 8, p. 1265, doi. 10.3390/molecules22081265
- By:
- Publication type:
- Article
Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation.
- Published in:
- Molecules, 2017, v. 22, n. 6, p. 1006, doi. 10.3390/molecules22061006
- By:
- Publication type:
- Article
7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment.
- Published in:
- Molecules, 2015, v. 20, n. 12, p. 22084, doi. 10.3390/molecules201219836
- By:
- Publication type:
- Article